Article

Deficits in response inhibition associated with chronic methamphetamine abuse

Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90024-1759, USA.
Drug and Alcohol Dependence (Impact Factor: 3.42). 09/2005; 79(2):273-7. DOI: 10.1016/j.drugalcdep.2005.02.002
Source: PubMed

ABSTRACT

Chronic methamphetamine (MA) abuse is associated with cerebral deficits, involving frontal/basal-ganglia regions that are important for inhibitory control. We used the Stop-Signal Task to measure response inhibition in 11 MA abusers (5-7 days abstinent) and two groups of control subjects who did not use MA (14 tobacco smokers and 29 non-smokers). Stop-signal reaction time (SSRT), which indicates the latency to inhibit an initiated motor response, was significantly longer for MA abusers than for either control group (p's<.01). In contrast, the MA abusers did not differ from either group on Go trial reaction time (RT) or number of discrimination errors, which reflect motor speed and decision-processes, respectively. MA abuse in this study was therefore associated with a specific deficit in inhibiting a pre-potent response. Future research could examine whether SSRT is different for MA abusers who respond to treatment compared to those who do not. If such differences are established then response inhibition may serve as a marker for investigating MA abuse in basic science and clinical trials.

Download full-text

Full-text

Available from: Edythe D London
  • Source
    • "Concurrently, neurocognitive mechanisms of inhibitory control are undermined in SUDs, as exemplified by compulsive drug use even in the face of negative consequences. Not surprisingly, on inhibitory control tasks, nonaddicted individuals significantly outperform those who chronically use alcohol (Kamarajan et al., 2005), stimulants (Hester and Garavan, 2004;Monterosso et al., 2005), and opioids (Fu et al., 2008). Functional neuroimaging studies of addicted populations have demonstrated that the key regions associated with these control deficits are the anterior cingulate cortex , dorsolateral prefrontal cortex, and orbitofrontal cortex (Goldstein and Volkow, 2011;Motzkin et al., 2014), and structural neuroimaging studies have found that these regions are smaller in individuals with SUDs, with reductions proportionate to severity and/or length of use (Ersche et al., 2013;Goldstein and Volkow, 2011;Liu et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Existing pharmacological treatments for alcohol use disorder (AUD) and other substance use disorders (SUDs) have demonstrated only modest efficacy. Although the field has recently emphasized testing and developing new compounds to treat SUDs, there are numerous challenges inherent to the development of novel medications, and this is particularly true for SUDs. Thus, research to date has tended toward the “repurposing” approach, in which medications developed to treat other mental or physical conditions are tested as SUD treatments. Often, potential treatments are examined across numerous drugs of abuse. Several repurposed medications have shown promise in treating a specific SUD, but few have shown efficacy across multiple SUDs. Examining similarities and differences between AUD and other SUDs may shed light on these findings and offer directions for future research.Methods This qualitative review discusses similarities and differences in neural circuitry and molecular mechanism(s) across alcohol and other substances of abuse, and examines studies of pharmacotherapies for AUD and other SUDs.ResultsSubstances of abuse share numerous molecular targets and involve much of the same neural circuitry, yet compounds tested because they putatively target common mechanisms have rarely indicated therapeutic promise for multiple SUDs.Conclusions The lack of treatment efficacy across SUDs may be partially explained by limitations inherent in studying substance users, who comprise a highly heterogeneous population. Alternatively, medications may fail to show efficacy across multiple SUDs due to the fact that the differences between drug mechanisms are more important than their commonalities in terms of influencing treatment response. We suggest that exploring these differences could support novel treatment development, aid in identifying existing medications that may hold promise as treatments for specific SUDs, and ultimately advance translational research efforts.
    Full-text · Article · Sep 2015 · Alcoholism Clinical and Experimental Research
  • Source
    • "This lack of information on the effects of IC training on behavior and on the anatomo-functional organization of the brain contrasts with the increasing number of studies that has focused on the effects of training in other executive functions (e.g., working memory: Klingberg 2010; or attention: Kramer et al. 1995; Green and Bavelier 2012; Slagter 2012). Beyond its conceptual importance , this question has a clinical relevance as deficits in IC represent a core component of several psychiatric disorders ranging from addiction (Harle et al. 2014; Monterosso et al. 2005) to attention deficit hyperactivity disorder (ADHD; e.g., Johnstone et al. 2012). Improving IC proficiency and the underlying brain networks with training may, thus, help the rehabilitation of inhibition-related brain disorders. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ample evidence indicates that inhibitory control (IC), a key executive component referring to the ability to suppress cognitive or motor processes, relies on a right-lateralized fronto-basal brain network. However, whether and how IC can be improved with training and the underlying neuroplastic mechanisms remains largely unresolved. We used functional and structural magnetic resonance imaging to measure the effects of 2 weeks of training with a Go/NoGo task specifically designed to improve frontal top-down IC mechanisms. The training-induced behavioral improvements were accompanied by a decrease in neural activity to inhibition trials within the right pars opercularis and triangularis, and in the left pars orbitalis of the inferior frontal gyri. Analyses of changes in brain anatomy induced by the IC training revealed increases in grey matter volume in the right pars orbitalis and modulations of white matter microstructure in the right pars triangularis. The task-specificity of the effects of training was confirmed by an absence of change in neural activity to a control working memory task. Our combined anatomical and functional findings indicate that differential patterns of functional and structural plasticity between and within inferior frontal gyri enhanced the speed of top-down inhibition processes and in turn IC proficiency. The results suggest that training-based interventions might help overcoming the anatomic and functional deficits of inferior frontal gyri manifesting in inhibition-related clinical conditions. More generally, we demonstrate how multimodal neuroimaging investigations of training-induced neuroplasticity enable revealing novel anatomo-functional dissociations within frontal executive brain networks. Hum Brain Mapp, 2015. © 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.
    Full-text · Article · Mar 2015 · Human Brain Mapping
  • Source
    • "The present study used the stop-signal task as probe for characterizing prefrontal dysfunction in MAP and schizophrenia as problematic drug use is associated with difficulty in exerting inhibitory control over behaviors and methamphetamine abusers showed deficits in performance in this task (Monterosso et al. 2005). This task is designed to assess inhibitory control (Gordon, Schachar & Tannock 1997), during which participants are required to perform a choice reaction (go) task and to inhibit their responses to the task when they receive a stop-signal (Verbruggen, Logan & Stevens 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Methamphetamine abuse and dependence, frequently accompanied by schizophrenia-like psychotic symptoms [methamphetamine-associated psychosis (MAP)], is a serious public health problem worldwide. Few studies, however, have characterized brain dysfunction associated with MAP, nor investigated similarities and differences in brain dysfunction between MAP and schizophrenia. We compared prefrontal cortical activity associated with stop-signal inhibitory task in 21 patients with MAP, 14 patients with schizophrenia and 21 age- and gender-matched healthy controls using a 52-channel near-infrared spectroscopy (NIRS) system. Both the MAP and the schizophrenia groups showed significantly reduced activation in the bilateral ventrolateral prefrontal cortex compared with controls; however, only the MAP group showed reduced activation in the frontopolar prefrontal cortex. The MAP group demonstrated significant positive correlations between task performance and hemodynamic responses in the bilateral ventrolateral, polar and left dorsolateral regions of the prefrontal cortex. The MAP and schizophrenia groups demonstrated a significant difference in the relationship of impulsivity to hemodynamic changes in the bilateral premotor cortex. These findings characterize similarities and differences in prefrontal cortical dysfunction between psychosis associated with methamphetamine and schizophrenia. The reduced hemodynamic changes in the bilateral ventrolateral prefrontal cortex suggest a common underlying pathophysiology of MAP and schizophrenia, whereas those in the frontopolar prefrontal cortex point to an impaired state that is either inherent or caused specifically by methamphetamine use.
    Full-text · Article · Feb 2015 · Addiction Biology
Show more